Phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in selected patients (pts) with advanced non-small cell lung cancer (NSCLC) (IPASS): Evaluation of recruits in Japan
Other conference paper

Full Text

Times Cited
Web of Science4WOS source URL (as at 11/08/2020) Click here for the latest count

Other information
All Author(s) ListOhe Y, Ichinose Y, Nishiwaki Y, Yamamoto N, Negoro S, Duffield E, Jiang H, Saijo N, Mok T, Fukuoka M
Name of Conference45th Annual Meeting of the American-Society-of-Clinical-Oncology
Start Date of Conference29/05/2009
End Date of Conference02/06/2009
Place of ConferenceOrlando
Country/Region of ConferenceUnited States of America
Journal nameJournal of Clinical Oncology
Detailed descriptionorganized by ASCO,
Volume Number27
Issue Number15
PublisherAmerican Society of Clinical Oncology
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-12-08 at 02:35